Clinical Trials Update: Sept. 10, 2009
Sept. 11 -- (HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Schizophrenia
People aged 18 to 65 who have schizophrenia may qualify for this study. Participants will receive study medication and labs, and may be reimbursed for time and travel.
The research site is in Glendale, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/schizophrenia.aspx.
-----
Epilepsy
This study will evaluate any visual field changes in people taking pregabalin as an add-on therapy for partial epilepsy.
The research site is in Charleston, S.C.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/epilepsy.aspx.
-----
Depression
This study will evaluate an investigational medication for depression. People who qualify will receive study related evaluation and care at no cost, and a stipend for time and travel.
The research site is in Norristown, Penn.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/depression.aspx.
-----
Copyright 2009ClinicalConnection.com. All rights reserved.